These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 31799652
1. LINC01296 promotes the proliferation and invasion by regulating microRNA-760 expression and predicts poor prognosis of hepatocellular carcinoma. Wang ZC, Yang S, Chen MQ, Wu SS, Lv HH, Jin WX. Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9848-9856. PubMed ID: 31799652 [Abstract] [Full Text] [Related]
2. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis. Zhang L, Hu J, Hao M, Bu L. Biol Chem; 2020 Feb 25; 401(3):407-416. PubMed ID: 31318685 [Abstract] [Full Text] [Related]
3. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103. Ma CX, Gao WC, Tian L. Eur Rev Med Pharmacol Sci; 2019 Jun 25; 23(11):4713-4722. PubMed ID: 31210297 [Abstract] [Full Text] [Related]
4. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin. Li H, Yuan R, Wang H, Li C, Wei J. J BUON; 2020 Jun 25; 25(2):972-980. PubMed ID: 32521894 [Abstract] [Full Text] [Related]
5. Circ_0091579 promotes proliferative ability and metastasis of liver cancer cells by regulating microRNA-490-3p. Niu WY, Chen L, Zhang P, Zang H, Zhu B, Shao WB. Eur Rev Med Pharmacol Sci; 2019 Dec 25; 23(23):10264-10273. PubMed ID: 31841181 [Abstract] [Full Text] [Related]
6. Long-chain non-coding RNA LINC01554 promotes NGFR expression and inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma by binding to microRNA-3681-3p. Hao QY, Gao LH, Niu WY, Wang GJ, Zhang P, Chen L, Zhu DM, Shao WB. Eur Rev Med Pharmacol Sci; 2020 Dec 25; 24(24):12667-12674. PubMed ID: 33378013 [Abstract] [Full Text] [Related]
7. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1. Wei YY, Ren TL. Eur Rev Med Pharmacol Sci; 2020 Dec 25; 24(23):12144-12152. PubMed ID: 33336732 [Abstract] [Full Text] [Related]
8. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107. Wu XF, Lu JT, Chen W, Wang N, Meng JC, Zhou YH. Eur Rev Med Pharmacol Sci; 2019 Jan 25; 23(2):690-698. PubMed ID: 30720176 [Abstract] [Full Text] [Related]
9. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L, Han T, Liu K, Lei CG, Wang ZC, Shi GJ. Eur Rev Med Pharmacol Sci; 2019 Jun 25; 23(12):5392-5401. PubMed ID: 31298392 [Abstract] [Full Text] [Related]
10. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway. Ye J, Jiao Y. Eur Rev Med Pharmacol Sci; 2019 Jul 25; 23(13):5779-5786. PubMed ID: 31298329 [Abstract] [Full Text] [Related]
11. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p. Yao J, Fu J, Liu Y, Qu W, Wang G, Yan Z. Ann Hepatol; 2021 Jul 25; 23():100297. PubMed ID: 33346094 [Abstract] [Full Text] [Related]
12. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124. Zhang S, Liu Y, Liu Z, Zhang Y, Chen G, Li K, Tang K. J BUON; 2019 Jul 25; 24(6):2402-2410. PubMed ID: 31983112 [Abstract] [Full Text] [Related]
13. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p. Zheng SN, Ge DW, Tang J, Yang J, Yan JW, Qiu JJ, Yin ZW, Ni Y, Zhao L, Chen X, Yang L. Eur Rev Med Pharmacol Sci; 2019 Jan 25; 23(1):96-104. PubMed ID: 30657551 [Abstract] [Full Text] [Related]
14. Long noncoding RNA LINC01296 regulates the cell proliferation, migration and invasion in neuroblastoma. Xiao H, Li Y, Zhang Y, Wang P. Metab Brain Dis; 2022 Apr 25; 37(4):1247-1258. PubMed ID: 35305236 [Abstract] [Full Text] [Related]
15. Circ_0000064 adsorption of microRNA-143 promotes malignant progression of hepatocellular carcinoma. Wu L, Xu XM, Li Y, Fan L. Eur Rev Med Pharmacol Sci; 2019 Nov 25; 23(21):9321-9330. PubMed ID: 31773699 [Abstract] [Full Text] [Related]
16. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p. Chen AY, Zhang K, Liu GQ. Eur Rev Med Pharmacol Sci; 2020 Sep 25; 24(18):9315-9324. PubMed ID: 33015772 [Abstract] [Full Text] [Related]
17. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma. Liu W, Zhang GQ, Zhu DY, Wang LJ, Li GT, Xu JG, Jin XL, Zhu YM, Yang XY. Eur Rev Med Pharmacol Sci; 2020 Jul 25; 24(14):7612-7620. PubMed ID: 32744687 [Abstract] [Full Text] [Related]
18. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis. Liao Z, Zhang H, Su C, Liu F, Liu Y, Song J, Zhu H, Fan Y, Zhang X, Dong W, Chen X, Liang H, Zhang B. J Exp Clin Cancer Res; 2021 Jan 23; 40(1):36. PubMed ID: 33485374 [Abstract] [Full Text] [Related]
19. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion. Wang B, Liang T, Li J. Eur Rev Med Pharmacol Sci; 2018 Jul 23; 22(14):4524-4531. PubMed ID: 30058683 [Abstract] [Full Text] [Related]
20. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186. Luo X, Song Y, Tang L, Sun DH, Ji DG. Eur Rev Med Pharmacol Sci; 2018 Nov 23; 22(22):7788-7797. PubMed ID: 30536320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]